Global Cardiotocograph (CTG) Market Strategic Research Report

Scope of the Report

The global Cardiotocograph (CTG) market size is predicted to grow from US$ 408 million in 2025 to US$ 561 million in 2032; it is expected to grow at a CAGR of 4.7% from 2026 to 2032.

Cardiotocography (CTG), also known as Electronic Fetal Monitoring (EFM), which can monitor both the fetal heart rate and uterine contractions. This method provides a paper recording of the fetal heart rate and the uterine contractions, but prevents the mother from leaving the hospital bed and restricts general movement.

The cardiotocograph (CTG) market is being driven by the growing global emphasis on improving maternal and fetal health outcomes. CTG is a vital prenatal monitoring technology used to assess fetal heart rate and uterine contractions during pregnancy and labor, helping healthcare providers detect fetal distress and prevent complications such as hypoxia or stillbirth. The rising global birth rate, especially in developing countries, and increasing awareness of prenatal care are boosting the demand for CTG devices. In developed regions, the adoption of advanced and digital CTG systems is fueled by technological innovations, including wireless monitoring, real-time data integration with electronic medical records, and remote patient monitoring capabilities. These innovations enhance clinical decision-making and workflow efficiency, especially in high-risk pregnancies. Additionally, government initiatives and funding aimed at reducing maternal and infant mortality—such as those led by the WHO and national health programs—are supporting the expansion of prenatal monitoring infrastructure. Private and public investments in modernizing healthcare facilities and the growing number of maternity clinics and hospitals globally also contribute to the market’s positive trajectory.

Despite its benefits, the CTG market faces several challenges that could hinder broader adoption. One of the primary issues is the lack of trained healthcare professionals in many low- and middle-income countries, which limits the effective use and interpretation of CTG data. In these regions, outdated or insufficient monitoring infrastructure further hampers accurate prenatal assessment. Moreover, CTG interpretation can be subjective and prone to variability among clinicians, leading to false positives and unnecessary interventions such as cesarean sections, which raise healthcare costs and risks. There is also a growing debate in the medical community about the overuse of CTG in low-risk pregnancies, with some studies suggesting it does not significantly reduce neonatal morbidity or mortality in such cases. Additionally, the high cost of advanced CTG machines with integrated digital and telemetry functions may be prohibitive for smaller clinics and rural hospitals. Data privacy and integration concerns also arise when using cloud-based or wireless systems, especially in regions with limited digital infrastructure or unclear data protection laws. Addressing these challenges will require not only technological innovation but also investment in training, standardization of interpretation protocols, and equitable access to quality maternal healthcare.

This report presents a comprehensive overview of the global Cardiotocograph (CTG) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Traditional CTG
• Intelligent CTG

Segment by Application

• Hospital
• Clinical
• Home

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cardiotocograph (CTG) market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Clinical, Home evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact